Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in bharat biotech

Bharat Biotech Hopeful To Get Regulator's Nod For Intranasal Covid Vaccine

The Drug Controller General of India gave its nod to conduct clinical trials for BBIL's intranasal vaccine as booster dose. Separately, the DCGI also granted permission to the firm to conduct phase-3 clinical trial to compare the immunogenecity and safety of BBV-154 (intranasal) with Covaxin. This trial has been permitted to be conducted at nine sites

Read More

Bharat Biotech Expects To Get A Nod For Its Intranasal Covid-19 Vaccine By Aug

The Drug Controller General approved the official trials on the intranasal Covid-19 vaccine and so the company is hopeful of getting regulatory licenses in August.

Read More

Covaxin Proven Safe For Children Of 2-18 Years Age Group In Phase III Study: Bharat Biotech

Bharat Biotech said in the study, no serious adverse event was reported. A total of 374 adverse events were reported, and the majority of adverse events were mild in nature and resolved within one day. Pain at the injection site was the most commonly reported adverse event

Read More

Bharat Biotech Must Address Vaccine Issues Raised By WHO, Says MEA

Weeks after WHO suspended the supply of Covaxin through UN procurement agencies, the MEA suggested that Bharat Biotech addresses the issue immediately to avoid the cancellation

Read More

Covaxin Gets Emergency Use Authorisation For Children Aged 6-12: Sources

The development comes after the Subject Expert Committee (SEC) of the DCGI asked Bharat Biotech for additional data on Covaxin, for administering it to children aged between 2-12 years, sources said

Read More

Covaxin Booster Amplifies Protection Against Variants Of Concern: ICMR Study

As a part of the study the antibody responses in sera of 51 participants who received two doses of Covaxin collected six months post second dose and 28 days after receiving a third (booster) dose (given on day 215th post second dose) and its impact against the Omicron VoC was evaluated

Read More

Covishield And Covaxin Doses To Cost Rs 225 Now In Private Hospitals

The Serum Institute of India has cut the rates of Covishield from ₹600 to ₹225 per dose, while Bharat Biotech has brought down the price of Covaxin from ₹1,200 to ₹225

Read More

Bharat Biotech To Slow Down Covaxin Production

During the recent WHO post EUL inspection, the vaccine manufacturer agreed with the WHO team on the scope of the planned improvement activities and indicated that they will be executed as soon as practical

Read More

Bharat Biotech Says Supply Chains Not Impacted By Russia-Ukraine Conflict

A few Indian pharmaceutical companies have a presence in Russia, exporting and selling medicines in the country. Sales to Russia between April and December last year reached $386 million, or 15% of the total exports to the country

Read More

Govt Expert Panel Recommends Regular Market Approval For Covishield, Covaxin

Pharma companies Serum Institute of India (SII) and Bharat Biotech had submitted applications to the Drugs Controller General of India (DCGI) seeking regular market authorisation for their respective COVID-19 vaccines Covishield and Covaxin.

Read More

After Serum, Bharat Biotech Seeks Regular Marketing Approval For Covaxin

DCGI had asked for some more information following which Singh last week submitted a response along with all desired data and information to DCGI.

Read More

Bharat Biotech's Covaxin Now On UK's Approved Travel List

The Bharat Biotech manufactured Covaxin - the second most used formulation in India - had received its WHO EUL status, resulting in the UK announcing plans to include it on its list of approved COVID vaccines from November 22.

Read More

Covaxin 77.8% Effective Against COVID-19: Lancet Study

The efficacy analysis demonstrated that Covaxin to be 93.4 per cent effective against severe symptomatic Covid-19.

Read More

Bharat Biotech's Partner Ocugen Files EUA Request With FDA For Paediatric Use Of Covaxin

Having a new type of vaccine available will enable people to discuss with their child's physician the best approach for them to lower their child's risk of contracting COVID-19

Read More

'We Trust Indian Industry, Bharat Biotech Submitting Data Regularly, Very Quickly': WHO Official On Covaxin EUL

Hyderabad-based Bharat Biotech, which has developed Covaxin, had submitted EOI (Expression of Interest) to the World Health Organisation on April 19 for the vaccine's Emergency Use Listing (EUL).

Read More